RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Clinical trial NCT00443846 · COMPLETED

Trial details

NCT number: NCT00443846
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningitis, Meningococcal Rotavirus Infections

Start date: 2007-02-13
Primary completion: 2007-09-04
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.